vs
Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
Emerald Holding, Inc. is the larger business by last-quarter revenue ($132.7M vs $123.8M, roughly 1.1× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -22.8%, a 26.1% gap on every dollar of revenue. On growth, Emerald Holding, Inc. posted the faster year-over-year revenue change (24.3% vs 4.7%). Emerald Holding, Inc. produced more free cash flow last quarter ($11.7M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -0.3%).
TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
EEX vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $132.7M | $123.8M |
| Net Profit | $-30.2M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | -11.8% | 4.3% |
| Net Margin | -22.8% | 3.3% |
| Revenue YoY | 24.3% | 4.7% |
| Net Profit YoY | -692.2% | 1379.4% |
| EPS (diluted) | $-0.15 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $132.7M | $123.8M | ||
| Q3 25 | $77.5M | $128.3M | ||
| Q2 25 | $105.5M | $114.8M | ||
| Q1 25 | $147.7M | $113.2M | ||
| Q4 24 | $106.8M | $118.2M | ||
| Q3 24 | $72.6M | $114.6M | ||
| Q2 24 | $86.0M | $110.6M | ||
| Q1 24 | $133.4M | $111.0M |
| Q4 25 | $-30.2M | $4.1M | ||
| Q3 25 | $-14.4M | $5.3M | ||
| Q2 25 | $-1.4M | $5.3M | ||
| Q1 25 | $15.3M | $4.7M | ||
| Q4 24 | $5.1M | $-321.0K | ||
| Q3 24 | $-11.1M | $4.3M | ||
| Q2 24 | $-2.8M | $1.3M | ||
| Q1 24 | $11.0M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% | ||
| Q1 24 | — | 71.2% |
| Q4 25 | -11.8% | 4.3% | ||
| Q3 25 | -10.1% | 7.0% | ||
| Q2 25 | 9.7% | 3.7% | ||
| Q1 25 | 24.2% | 5.4% | ||
| Q4 24 | 19.5% | 3.8% | ||
| Q3 24 | -6.5% | 4.6% | ||
| Q2 24 | 7.4% | 5.1% | ||
| Q1 24 | 18.2% | 4.2% |
| Q4 25 | -22.8% | 3.3% | ||
| Q3 25 | -18.6% | 4.2% | ||
| Q2 25 | -1.3% | 4.6% | ||
| Q1 25 | 10.4% | 4.2% | ||
| Q4 24 | 4.8% | -0.3% | ||
| Q3 24 | -15.3% | 3.8% | ||
| Q2 24 | -3.3% | 1.2% | ||
| Q1 24 | 8.2% | 2.1% |
| Q4 25 | $-0.15 | $0.23 | ||
| Q3 25 | $-0.07 | $0.30 | ||
| Q2 25 | $-0.01 | $0.28 | ||
| Q1 25 | $0.08 | $0.25 | ||
| Q4 24 | $0.01 | $-0.02 | ||
| Q3 24 | $-0.05 | $0.23 | ||
| Q2 24 | $-0.03 | $0.07 | ||
| Q1 24 | $0.00 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $100.9M | $93.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.8M | $161.6M |
| Total Assets | $1.2B | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $100.9M | $93.9M | ||
| Q3 25 | $95.4M | $95.6M | ||
| Q2 25 | $156.4M | $81.3M | ||
| Q1 25 | $276.8M | $86.5M | ||
| Q4 24 | $194.8M | $84.7M | ||
| Q3 24 | $188.9M | $78.7M | ||
| Q2 24 | $193.2M | $68.7M | ||
| Q1 24 | $186.8M | $77.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.1M |
| Q4 25 | $338.8M | $161.6M | ||
| Q3 25 | $369.5M | $166.7M | ||
| Q2 25 | $389.4M | $163.7M | ||
| Q1 25 | $392.1M | $167.1M | ||
| Q4 24 | $385.9M | $161.0M | ||
| Q3 24 | $391.1M | $162.6M | ||
| Q2 24 | $407.6M | $156.4M | ||
| Q1 24 | $-90.7M | $159.7M |
| Q4 25 | $1.2B | $261.1M | ||
| Q3 25 | $1.2B | $264.8M | ||
| Q2 25 | $1.2B | $254.9M | ||
| Q1 25 | $1.2B | $252.7M | ||
| Q4 24 | $1.0B | $240.9M | ||
| Q3 24 | $1.1B | $245.3M | ||
| Q2 24 | $1.1B | $235.8M | ||
| Q1 24 | $1.1B | $247.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $9.9M |
| Free Cash FlowOCF − Capex | $11.7M | $7.6M |
| FCF MarginFCF / Revenue | 8.8% | 6.1% |
| Capex IntensityCapex / Revenue | 0.5% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $41.4M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | $9.9M | ||
| Q3 25 | $1.8M | $18.5M | ||
| Q2 25 | $15.9M | $4.3M | ||
| Q1 25 | $12.6M | $2.6M | ||
| Q4 24 | $20.6M | $12.2M | ||
| Q3 24 | $9.1M | $9.6M | ||
| Q2 24 | $9.8M | $1.3M | ||
| Q1 24 | $7.3M | $2.2M |
| Q4 25 | $11.7M | $7.6M | ||
| Q3 25 | $1.5M | $16.8M | ||
| Q2 25 | $15.8M | $3.0M | ||
| Q1 25 | $12.4M | $1.5M | ||
| Q4 24 | $19.9M | $10.0M | ||
| Q3 24 | $9.0M | $7.9M | ||
| Q2 24 | $9.6M | $-2.0M | ||
| Q1 24 | $7.0M | $-1.5M |
| Q4 25 | 8.8% | 6.1% | ||
| Q3 25 | 1.9% | 13.1% | ||
| Q2 25 | 15.0% | 2.6% | ||
| Q1 25 | 8.4% | 1.3% | ||
| Q4 24 | 18.6% | 8.5% | ||
| Q3 24 | 12.4% | 6.9% | ||
| Q2 24 | 11.2% | -1.9% | ||
| Q1 24 | 5.2% | -1.4% |
| Q4 25 | 0.5% | 1.9% | ||
| Q3 25 | 0.4% | 1.3% | ||
| Q2 25 | 0.1% | 1.2% | ||
| Q1 25 | 0.1% | 1.0% | ||
| Q4 24 | 0.7% | 1.9% | ||
| Q3 24 | 0.1% | 1.5% | ||
| Q2 24 | 0.2% | 3.0% | ||
| Q1 24 | 0.2% | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | 0.82× | 0.55× | ||
| Q4 24 | 4.04× | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | 0.66× | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EEX
| Connections Segment | $121.9M | 92% |
| Commerce Segment | $5.5M | 4% |
| Content | $5.3M | 4% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
